KR20230153847A - Antibacterial toothpaste composition with excellent effect of preventing gum disease and removing bad breath - Google Patents
Antibacterial toothpaste composition with excellent effect of preventing gum disease and removing bad breath Download PDFInfo
- Publication number
- KR20230153847A KR20230153847A KR1020220053798A KR20220053798A KR20230153847A KR 20230153847 A KR20230153847 A KR 20230153847A KR 1020220053798 A KR1020220053798 A KR 1020220053798A KR 20220053798 A KR20220053798 A KR 20220053798A KR 20230153847 A KR20230153847 A KR 20230153847A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- parts
- gum
- bad breath
- Prior art date
Links
- 239000000606 toothpaste Substances 0.000 title claims abstract description 61
- 229940034610 toothpaste Drugs 0.000 title claims abstract description 59
- 206010006326 Breath odour Diseases 0.000 title claims abstract description 42
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 230000000694 effects Effects 0.000 title claims abstract description 23
- 208000024693 gingival disease Diseases 0.000 title claims abstract description 19
- 229920000175 Pistacia lentiscus Polymers 0.000 claims abstract description 27
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000796 flavoring agent Substances 0.000 claims abstract description 18
- 235000002020 sage Nutrition 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 14
- 235000019634 flavors Nutrition 0.000 claims abstract description 14
- 239000000600 sorbitol Substances 0.000 claims abstract description 14
- 241000241413 Propolis Species 0.000 claims abstract description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 13
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 13
- 229940069949 propolis Drugs 0.000 claims abstract description 13
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims abstract description 12
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 12
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 12
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 12
- 239000000811 xylitol Substances 0.000 claims abstract description 12
- 235000010447 xylitol Nutrition 0.000 claims abstract description 12
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 12
- 229960002675 xylitol Drugs 0.000 claims abstract description 12
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 11
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 11
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 11
- 229960001866 silicon dioxide Drugs 0.000 claims abstract description 11
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 10
- 240000005428 Pistacia lentiscus Species 0.000 claims abstract description 10
- 244000269722 Thea sinensis Species 0.000 claims abstract description 10
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940094952 green tea extract Drugs 0.000 claims abstract description 10
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 10
- 239000008213 purified water Substances 0.000 claims abstract description 10
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 9
- 240000004371 Panax ginseng Species 0.000 claims abstract description 9
- 235000004768 Pistacia lentiscus Nutrition 0.000 claims abstract description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 9
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims abstract description 9
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000008434 ginseng Nutrition 0.000 claims abstract description 9
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 9
- 239000001683 mentha spicata herb oil Substances 0.000 claims abstract description 9
- 229960004029 silicic acid Drugs 0.000 claims abstract description 9
- 235000019721 spearmint oil Nutrition 0.000 claims abstract description 9
- 235000019202 steviosides Nutrition 0.000 claims abstract description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 8
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 8
- 241001529742 Rosmarinus Species 0.000 claims abstract description 8
- 244000178231 Rosmarinus officinalis Species 0.000 claims abstract description 8
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 8
- 235000002912 Salvia officinalis Nutrition 0.000 claims abstract description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 8
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 8
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000294 eucalyptus globulus labille leaf/twig oil Substances 0.000 claims abstract description 8
- 229940107131 ginseng root Drugs 0.000 claims abstract description 8
- 229940092258 rosemary extract Drugs 0.000 claims abstract description 8
- 235000020748 rosemary extract Nutrition 0.000 claims abstract description 8
- 235000015639 rosmarinus officinalis Nutrition 0.000 claims abstract description 8
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims abstract description 8
- 229940112950 sage extract Drugs 0.000 claims abstract description 8
- 235000020752 sage extract Nutrition 0.000 claims abstract description 8
- 239000011734 sodium Substances 0.000 claims abstract description 8
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 8
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940013618 stevioside Drugs 0.000 claims abstract description 8
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 7
- 230000006806 disease prevention Effects 0.000 claims abstract description 7
- 239000003205 fragrance Substances 0.000 claims description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 3
- 239000010642 eucalyptus oil Substances 0.000 claims description 3
- 229940044949 eucalyptus oil Drugs 0.000 claims description 3
- 229940041616 menthol Drugs 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 abstract description 16
- 239000004094 surface-active agent Substances 0.000 abstract description 10
- 238000004140 cleaning Methods 0.000 abstract description 8
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 abstract description 6
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 abstract description 6
- 208000007565 gingivitis Diseases 0.000 abstract description 6
- 201000001245 periodontitis Diseases 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 229960002920 sorbitol Drugs 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 20
- 238000012360 testing method Methods 0.000 description 14
- 210000000214 mouth Anatomy 0.000 description 13
- 230000001680 brushing effect Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 208000028169 periodontal disease Diseases 0.000 description 9
- 230000001954 sterilising effect Effects 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- 244000166124 Eucalyptus globulus Species 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 235000014749 Mentha crispa Nutrition 0.000 description 4
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002324 mouth wash Substances 0.000 description 4
- 229940051866 mouthwash Drugs 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 244000146462 Centella asiatica Species 0.000 description 3
- 235000004032 Centella asiatica Nutrition 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 235000014435 Mentha Nutrition 0.000 description 3
- 241001072983 Mentha Species 0.000 description 3
- 244000078639 Mentha spicata Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 244000228451 Stevia rebaudiana Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- -1 dimethyl mercaptan Chemical compound 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 235000021096 natural sweeteners Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 150000003568 thioethers Chemical class 0.000 description 3
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- JJMDCOVWQOJGCB-UHFFFAOYSA-N 5-aminopentanoic acid Chemical compound [NH3+]CCCCC([O-])=O JJMDCOVWQOJGCB-UHFFFAOYSA-N 0.000 description 2
- 241000186044 Actinomyces viscosus Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 208000005888 Periodontal Pocket Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000002882 anti-plaque Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229940091249 fluoride supplement Drugs 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 235000014569 mints Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 230000003239 periodontal effect Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 150000008144 steviol glycosides Chemical class 0.000 description 2
- 208000003265 stomatitis Diseases 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000034309 Bacterial disease carrier Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 244000182807 Mentha suaveolens Species 0.000 description 1
- 241001479543 Mentha x piperita Species 0.000 description 1
- 229920000426 Microplastic Polymers 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 206010034535 Periodontal destruction Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241001149563 Streptococcus mutans ATCC 25175 Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 239000007478 blood agar base Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- BFDWBSRJQZPEEB-UHFFFAOYSA-L sodium fluorophosphate Chemical compound [Na+].[Na+].[O-]P([O-])(F)=O BFDWBSRJQZPEEB-UHFFFAOYSA-L 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물에 관한 것이다.
본 발명의 기술적 사상의 일 실시예에 따른 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물은, 이산화규소(Silica), 일불소인산나트륨(Sodium Monofluorophospate), 토코페롤아세테이트(Tocopheryl Acetate), 소르비톨액(Sorbitol), 함수규산(Hydrated Silica), 카르복시메틸셀룰로오스나트륨(Cellulose Gum), 자일리톨(xylitol), 스테비올배당체(stevioside), 아스코르브산(ascorbic acid), L-멘톨(menthol), 프로폴리스추출물(propolis extract), 세이지추출물(salvia officinalis (sage) extract), 로즈마리추출물(rosmarinus officinalis (rosemary) extract), 병풀추출물(Centella asiatica extract), 녹차추출물(camellia sinensis leaf extract), 조합향료(수용성매스틱검)(Pistacia lentiscus (mastic) gum), 인삼추출물(panax ginseng root extract), 유칼립투스오일(eucalyptus globulus leaf oil), 스피아민트오일(spearmint oil), 향료(flavor) 및 정제수(water)를 포함한다.
상기한 구성에 의해 본 발명의 기술적 사상의 일 실시예에 의한 치약조성물은, 합성계면활성제 등 인체에 유해할 수 있는 성분을 사용하지 않고 치아세정 및 구취제거 효과와 더불어 치주염 및 치은염 등의 잇몸질환에 탁월한 효능을 발휘하여 구강 내 건강을 도모할 수 있다.The present invention relates to an antibacterial toothpaste composition that is effective in preventing gum disease and removing bad breath.
An antibacterial toothpaste composition with excellent gum disease prevention and bad breath removal effects according to an embodiment of the technical idea of the present invention includes silicon dioxide, sodium monofluorophospate, tocopheryl acetate, and sorbitol solution ( Sorbitol, Hydrated Silica, Carboxymethyl Cellulose Sodium (Cellulose Gum), xylitol, stevioside, ascorbic acid, L-menthol, propolis extract extract), sage extract (salvia officinalis (sage) extract), rosemary extract (rosmarinus officinalis (rosemary) extract), Centella asiatica extract, green tea extract (camellia sinensis leaf extract), combined flavor (water-soluble mastic gum) (Pistacia lentiscus (mastic) gum), ginseng extract (panax ginseng root extract), eucalyptus globulus leaf oil, spearmint oil, flavor and purified water.
With the above configuration, the toothpaste composition according to an embodiment of the technical idea of the present invention has the effect of cleaning teeth and removing bad breath without using ingredients that may be harmful to the human body, such as synthetic surfactants, as well as gum diseases such as periodontitis and gingivitis. It has excellent efficacy and can promote oral health.
Description
본 발명은 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물에 관한 것으로서, 더욱 상세하게는 합성계면활성제 등 인체에 유해할 수 있는 성분을 사용하지 않고 치아세정 및 구취제거 효과와 더불어 치주염 및 치은염 등의 잇몸질환에 탁월한 효능을 발휘하여 구강 내 건강을 도모할 수 있는 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물에 관한 것이다.The present invention relates to an antibacterial toothpaste composition that is excellent in preventing gum disease and removing bad breath. More specifically, it relates to an antibacterial toothpaste composition that is effective in cleaning teeth and removing bad breath without using ingredients that may be harmful to the human body such as synthetic surfactants, as well as in periodontitis and gingivitis. This relates to an antibacterial toothpaste composition that is effective in preventing gum disease and eliminating bad breath, which can promote oral health by demonstrating excellent efficacy against gum disease.
일반적으로 구취는 후천적인 전신질환에 의하거나, 타액중의 단백질, 음식물 잔사 등이 미생물에 의해 분해되어 생성된 아미노산이 탈회산효소나 아미노효소 등에 의해 분해되어 악취를 유발하는 물질을 생성함으로써 발생되는데, 이 중 마늘이나 고추 등의 물질에 함유되어 있는 황화물의 분해시 발생되는 구취가 매우 역겨운 것으로 알려져 있다.In general, bad breath is caused by an acquired systemic disease or when proteins and food residues in saliva are decomposed by microorganisms and amino acids produced are decomposed by deoxidation enzymes or amino enzymes to produce substances that cause bad odor. , Among these, the bad breath that occurs when sulfides contained in substances such as garlic or pepper are decomposed is known to be very disgusting.
구취를 유발하는 대표적인 성분으로는 휘발성 황화물(Volatile Sulfide Compounds; 이하, VSC로 약칭한다)을 들 수 있는데, 이들 휘발성 황화물에는 황화수소(Hydrogen sulfide, H2S), 메틸머캅탄(Methyl mercaptan, CH3SH), 디메틸머캅탄[Dimethyl mercaptan, (CH3)2S] 등이 있으며, 특히 메틸머캅탄은 구취 중 역겨운 냄새의 주성분이라고 알려져 있다. 또한, 생선의 경우 그 신선도가 떨어짐에 따라 생선 비린내인 트리메틸아민[Trimethyl amine, (CH3)3N] 또는 δ- 아미노발레린산(δ-Aminovaleric acid) 등이 형성되며, 이들 휘발성 아민화합물 특히, 트리메틸아민이 악취성분의 주요한 부분을 이루고 있다. 그 외의 구취 유발물질로는 알데히드, 지방산, 암모니아 또는 피리딘 등이 있다.Representative ingredients that cause bad breath include Volatile Sulfide Compounds (hereinafter abbreviated as VSC). These volatile sulfides include Hydrogen sulfide (H 2 S) and Methyl mercaptan (CH 3) . SH), dimethyl mercaptan, (CH 3 ) 2 S], etc., and in particular, methyl mercaptan is known to be the main component of the disgusting smell of bad breath. In addition, in the case of fish, as the freshness decreases, fishy smell such as trimethyl amine ((CH 3 ) 3 N) or δ-aminovaleric acid is formed, and these volatile amine compounds, especially, Trimethylamine forms a major part of the odor component. Other substances that cause bad breath include aldehydes, fatty acids, ammonia, or pyridine.
그리고 구내염은 입술, 입안, 혀, 볼 안쪽 등 구강 내에 나타나는 모든 염증성 병변을 통칭한다. 대개는 하얗게 움푹 패인 모양으로 나타나는데, 한번 발생하면 구취, 물집, 궤양 등의 증세를 동반하고 통증이 심해 음식을 씹거나 삼키는 것조차 힘든 경우도 많다. 구내염은 보통 여름철에 더 많이 발생하는 특징이 있다.Stomatitis refers to all inflammatory lesions that appear in the oral cavity, including the lips, mouth, tongue, and inside the cheeks. It usually appears as a white depression, and once it occurs, it is accompanied by symptoms such as bad breath, blisters, and ulcers, and the pain is so severe that it is often difficult to even chew or swallow food. Stomatitis usually occurs more often in the summer.
또한, 치은염 및 치주병을 포함하는 치주질환은 세균에 의해 야기되는 치아 지지 조직의 염증상태로서, 출혈, 치주낭의 형성 및 치조골의 파괴 등으로 인하여 치아의 상실을 가져오는 질환이다. 이러한 치주질환은 세균의 집락형성, 세균의 치주조직 침투 및 치주조직 파괴의 과정으로 진행된다.Additionally, periodontal disease, including gingivitis and periodontal disease, is an inflammatory condition of the tooth-supporting tissue caused by bacteria, and is a disease that results in tooth loss due to bleeding, formation of periodontal pockets, and destruction of alveolar bone. This periodontal disease progresses through the process of bacterial colonization, bacterial invasion of periodontal tissue, and destruction of periodontal tissue.
구체적으로, 불량한 구강 위생 상태로 인하여 구강 세균이 치면 세균막을 형성하면 염증이 생겨 가끔 잇몸에서 피가 나고 구취가 나며, 이러한 상태로 더 진행되면 치아와 잇몸 사이의 벌어진 틈이 더 깊어져서 치주낭이 생기고, 여기에 치주질환을 일으키는 세균들이 번식하여 치주염이 발생된다.Specifically, due to poor oral hygiene, oral bacteria form a bacterial film that causes inflammation, which sometimes causes the gums to bleed and bad breath. If this condition progresses further, the gaps between the teeth and gums become deeper, forming periodontal pockets. , bacteria that cause periodontal disease multiply here, resulting in periodontitis.
종래에는 일반적인 치약조성물을 사용하여 양치함으로 구강 내 이물질을 제거하는 것으로 구취를 제거하거나 불화나트륨, 일불소인산나트륨 같은 불소화합물이나 트리클로산, 염산클로로헥사딘 등의 구강용 항균제를 사용하여 구취유발 원인 미생물을 제거하여 구취를 예방 또는 억제하여 왔다.Conventionally, bad breath is removed by brushing the teeth using a general toothpaste composition to remove foreign substances in the mouth, or by using fluorine compounds such as sodium fluoride and sodium monofluorophosphate or oral antibacterial agents such as triclosan and chlorohexadine hydrochloride, which cause bad breath. It has been used to prevent or suppress bad breath by removing .
그러나, 일반적인 치약조성물을 사용하여 양치함으로 구강 내 이물질을 제거하는 방법은 단기적으로 구취를 예방 및 억제할 수는 있지만 장시간 효과를 지속할 수 없으며, 트리클로산 및 염산클로로헥사딘, 불화나트륨과 일불소인산나트륨은 화학적합성품으로서 환경친화적인 제품이라고 말할 수 없다.However, the method of removing foreign substances in the oral cavity by brushing using general toothpaste compositions can prevent and suppress bad breath in the short term, but the effect cannot be maintained for a long time. Triclosan, chlorohexadine hydrochloride, sodium fluoride and monofluorophosphate Sodium is a chemically synthesized product and cannot be said to be an environmentally friendly product.
또한, 불화나트륨과 일불소인산나트륨 같은 불소화합물을 과량 사용할 경우에는 반상치와 같은 부작용이 있어서 식품의약품안전청에서도 치약조성물에 들어갈 수 있는 불소함량을 1000ppm 이하로 규정하고 있는 실정이다.In addition, when excessive use of fluorine compounds such as sodium fluoride and sodium monofluorophosphate has side effects such as tooth decay, the Food and Drug Safety Administration stipulates that the fluorine content that can be contained in toothpaste compositions is 1000 ppm or less.
또한, 구강에 적용되는 구취제거성분들은 구강점막을 통하여 생체에 유입되거나 위장관에 흘러 들어갈 수 있으므로, 특히 인체에 무해한 물질을 사용할 필요가 있고, 지속적인 구강내 세균억제 효과가 미약하여 제품에 적용했을 경우 치주질환 예방 및 치료, 충치예방 및 구취 제거효과가 미약하며, 사용성이 좋지 않다는 등의 문제점을 지니고 있다.In addition, bad breath removal ingredients applied to the oral cavity can enter the body or flow into the gastrointestinal tract through the oral mucosa, so it is necessary to use substances that are harmless to the human body, and when applied to products because the effect of continuously suppressing oral bacteria is weak. It has problems such as poor effectiveness in preventing and treating periodontal disease, preventing cavities, and removing bad breath, and is not very usable.
본 발명이 해결하고자 하는 과제는, 합성계면활성제 등 인체에 유해할 수 있는 성분을 사용하지 않고 치아세정 및 구취제거 효과와 더불어 치주염 및 치은염 등의 잇몸질환에 탁월한 효능을 발휘하여 구강 내 건강을 도모할 수 있는 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물을 제공하는데 있다.The problem that the present invention aims to solve is to promote oral health by cleaning teeth and removing bad breath, without using ingredients that may be harmful to the human body, such as synthetic surfactants, and by demonstrating excellent efficacy against gum diseases such as periodontitis and gingivitis. The goal is to provide an antibacterial toothpaste composition that is effective in preventing gum disease and eliminating bad breath.
또한, 본 발명이 해결하고자 하는 다른 과제는, 거품을 만들어내는 계면활성제를 사용하지 않아 칫솔질에 의한 미세거품만 생성되어 양치 후 입안에 남는 잔여감없이 더욱 깔끔해진 개운함을 느낄 수 있는 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물을 제공하는데 있다.In addition, another problem that the present invention aims to solve is the prevention of gum disease, which does not use surfactants that create foam, so only fine foam is generated by toothbrushing, so that you can feel a cleaner, refreshed feeling without any residue left in the mouth after brushing your teeth. The aim is to provide an antibacterial toothpaste composition with excellent bad breath removal effect.
또한, 본 발명이 해결하고자 하는 또 다른 과제는, 미세한 플라그까지 제거하여 양치 후 개운한 청량감과 아울러 미백 기능을 향상시킬 수 있는 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물을 제공하는데 있다.In addition, another problem to be solved by the present invention is to provide an antibacterial toothpaste composition that is excellent in preventing gum disease and removing bad breath, which can remove even fine plaque, provide a refreshing feeling after brushing teeth, and improve whitening function.
본 발명이 해결하고자 하는 다양한 과제들은 이상에서 언급한 과제들에 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.The various problems to be solved by the present invention are not limited to the problems mentioned above, and other problems not mentioned will be clearly understood by those skilled in the art from the description below.
본 발명의 기술적 사상의 일 실시예에 따른 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물은, 이산화규소(Silica), 일불소인산나트륨(Sodium Monofluorophospate), 토코페롤아세테이트(Tocopheryl Acetate), 소르비톨액(Sorbitol), 함수규산(Hydrated Silica), 카르복시메틸셀룰로오스나트륨(Cellulose Gum), 자일리톨(xylitol), 스테비올배당체(stevioside), 아스코르브산(ascorbic acid), L-멘톨(menthol), 프로폴리스추출물(propolis extract), 세이지추출물(salvia officinalis (sage) extract), 로즈마리추출물(rosmarinus officinalis (rosemary) extract), 병풀추출물(Centella asiatica extract), 녹차추출물(camellia sinensis leaf extract), 조합향료(수용성매스틱검)(Pistacia lentiscus (mastic) gum), 인삼추출물(panax ginseng root extract), 유칼립투스오일(eucalyptus globulus leaf oil), 스피아민트오일(spearmint oil), 향료(flavor) 및 정제수(water)를 포함한다.An antibacterial toothpaste composition with excellent gum disease prevention and bad breath removal effects according to an embodiment of the technical idea of the present invention includes silicon dioxide, sodium monofluorophospate, tocopheryl acetate, and sorbitol solution ( Sorbitol, Hydrated Silica, Carboxymethyl Cellulose Sodium (Cellulose Gum), xylitol, stevioside, ascorbic acid, L-menthol, propolis extract extract), sage extract (salvia officinalis (sage) extract), rosemary extract (rosmarinus officinalis (rosemary) extract), Centella asiatica extract, green tea extract (camellia sinensis leaf extract), combined flavor (water-soluble mastic gum) (Pistacia lentiscus (mastic) gum), ginseng extract (panax ginseng root extract), eucalyptus globulus leaf oil, spearmint oil, flavor and purified water.
상기 이산화규소(Silica) 5 내지 7 중량부, 일불소인산나트륨(Sodium Monofluorophospate) 0.5 내지 1 중량부, 토코페롤아세테이트(Tocopheryl Acetate) 0.05 내지 0.25 중량부, 소르비톨액(Sorbitol) 60 내지 70 중량부, 함수규산(Hydrated Silica) 8 내지 12 중량부, 카르복시메틸셀룰로오스나트륨(Cellulose Gum) 0.1 내지 0.3 중량부, 자일리톨(xylitol) 5 내지 10 중량부, 스테비올배당체(stevioside) 0.05 내지 0.15 중량부, 아스코르브산(ascorbic acid) 0.0005 내지 0.0015 중량부, L-멘톨(menthol) 0.2 내지 0.6 중량부, 프로폴리스추출물(propolis extract) 0.0005 내지 0.0015 중량부, 세이지추출물(salvia officinalis (sage) extract) 0.005 내지 0.015 중량부, 로즈마리추출물(rosmarinus officinalis (rosemary) extract) 0.0005 내지 0.0015 중량부, 병풀추출물(Centella asiatica extract) 0.0005 내지 0.0015 중량부, 녹차추출물(camellia sinensis leaf extract) 0.005 내지 0.015 중량부, 조합향료(수용성매스틱검)(Pistacia lentiscus (mastic) gum) 0.0005 내지 0.0015 중량부, 인삼추출물(panax ginseng root extract) 0.005 내지 0.015 중량부, 유칼립투스오일(eucalyptus globulus leaf oil) 0.0005 내지 0.0015 중량부, 스피아민트오일(spearmint oil) 0.1 내지 0.9 중량부, 향료(flavor) 0.1 내지 0.9 중량부 및 정제수(water) 8 내지 12 중량부의 중량 비율로 포함될 수 있다.5 to 7 parts by weight of silicon dioxide, 0.5 to 1 part by weight of sodium monofluorophospate, 0.05 to 0.25 parts by weight of tocopheryl acetate, 60 to 70 parts by weight of sorbitol, water 8 to 12 parts by weight of Hydrated Silica, 0.1 to 0.3 parts by weight of sodium carboxymethyl cellulose (Cellulose Gum), 5 to 10 parts by weight of xylitol, 0.05 to 0.15 parts by weight of stevioside, ascorbic acid ( ascorbic acid) 0.0005 to 0.0015 parts by weight, L-menthol (menthol) 0.2 to 0.6 parts by weight, propolis extract (propolis extract) 0.0005 to 0.0015 parts by weight, sage extract (salvia officinalis (sage) extract) 0.005 to 0.015 parts by weight, Rosemary extract (rosmarinus officinalis (rosemary) extract) 0.0005 to 0.0015 parts by weight, Centella asiatica extract (Centella asiatica extract) 0.0005 to 0.0015 parts by weight, green tea extract (camellia sinensis leaf extract) 0.005 to 0.015 parts by weight, combined flavor (water-soluble mastic gum) ) (Pistacia lentiscus (mastic) gum) 0.0005 to 0.0015 parts by weight, ginseng extract (panax ginseng root extract) 0.005 to 0.015 parts by weight, eucalyptus oil (eucalyptus globulus leaf oil) 0.0005 to 0.0015 parts by weight, spearmint oil It may be included in a weight ratio of 0.1 to 0.9 parts by weight, 0.1 to 0.9 parts by weight of flavor, and 8 to 12 parts by weight of purified water.
기타 실시예들의 구체적인 사항들은 상세한 설명에 포함되어 있다.Specific details of other embodiments are included in the detailed description.
본 발명의 기술적 사상의 일 실시예에 의한 치약조성물은, 합성계면활성제 등 인체에 유해할 수 있는 성분을 사용하지 않고 치아세정 및 구취제거 효과와 더불어 치주염 및 치은염 등의 잇몸질환에 탁월한 효능을 발휘하여 구강 내 건강을 도모할 수 있다.The toothpaste composition according to an embodiment of the technical idea of the present invention exhibits excellent efficacy against gum diseases such as periodontitis and gingivitis in addition to teeth cleaning and bad breath removal effects without using ingredients that may be harmful to the human body, such as synthetic surfactants. This can promote oral health.
또한, 본 발명의 기술적 사상의 일 실시예에 의한 치약조성물은, 거품을 만들어내는 계면활성제를 사용하지 않아 칫솔질에 의한 미세거품만 생성되어 양치 후 입안에 남는 잔여감없이 더욱 깔끔해진 개운함을 느낄 수 있다.In addition, the toothpaste composition according to an embodiment of the technical idea of the present invention does not use a surfactant that creates foam, so only fine foam is generated by brushing the teeth, so you can feel a cleaner, more refreshed feeling without any residue remaining in your mouth after brushing your teeth. there is.
또한, 본 발명의 기술적 사상의 일 실시예에 의한 치약조성물은, 항균효과 및 미세한 플라그까지 제거하여 양치 후 개운한 청량감과 아울러 미백 기능을 향상시킬 수 있다.In addition, the toothpaste composition according to an embodiment of the technical idea of the present invention has an antibacterial effect and removes even fine plaque, thereby providing a refreshing feeling after brushing teeth and improving whitening function.
본 발명의 기술적 사상의 실시예는, 구체적으로 언급되지 않은 다양한 효과를 제공할 수 있다는 것이 충분히 이해될 수 있을 것이다.It will be fully understood that embodiments of the technical idea of the present invention can provide various effects that are not specifically mentioned.
도 1은 실시예에 따른 치약의 살균 시험 결과를 보여주는 시험성적서이다.
도 2는 실시예에 따른 치약의 유해성분 포함 여부에 대한 확인서이다.Figure 1 is a test report showing the results of a sterilization test of toothpaste according to an example.
Figure 2 is a confirmation of whether toothpaste according to an example contains harmful ingredients.
본 발명의 이점 및 특징, 그리고 그것들을 달성하는 방법은 상세하게 후술되어 있는 실시예를 참조하면 명확해질 것이다. 그러나 본 발명은 여기서 설명되는 실시예들에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 실시예들은 개시된 내용이 철저하고 완전해질 수 있도록 그리고 당업자에게 본 발명의 사상이 충분히 전달될 수 있도록 하기 위해 제공되는 것이다.The advantages and features of the present invention, and methods for achieving them, will become clear with reference to the embodiments described in detail below. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, the embodiments introduced herein are provided so that the disclosure will be thorough and complete and so that the spirit of the invention can be sufficiently conveyed to those skilled in the art.
본 출원에서 사용한 용어는 단지 특정한 실시예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다.The terms used in this application are only used to describe specific embodiments and are not intended to limit the invention. Singular expressions include plural expressions unless the context clearly dictates otherwise.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미가 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 의미가 있는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as generally understood by a person of ordinary skill in the technical field to which the present invention pertains. Terms defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and should not be interpreted as having an ideal or excessively formal meaning unless explicitly defined in the present application. No.
이하, 본 발명의 기술적 사상의 일 실시예에 따른 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물에 대하여 바람직한 실시예를 들어 상세하게 설명한다.Hereinafter, an antibacterial toothpaste composition with excellent gum disease prevention and bad breath removal effects according to an embodiment of the technical idea of the present invention will be described in detail with preferred examples.
본 발명의 기술적 사상의 일 실시예에 따른 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물은, 이산화규소(Silica), 일불소인산나트륨(Sodium Monofluorophospate), 토코페롤아세테이트(Tocopheryl Acetate), 소르비톨액(70% 비결정성)(Sorbitol), 함수규산(Hydrated Silica), 카르복시메틸셀룰로오스나트륨(Cellulose Gum), 자일리톨(xylitol), 스테비올배당체(stevioside), 아스코르브산(ascorbic acid), L-멘톨(menthol), 프로폴리스추출물(propolis extract), 세이지추출물(salvia officinalis (sage) extract), 로즈마리추출물(rosmarinus officinalis (rosemary) extract), 병풀추출물(Centella asiatica extract), 녹차추출물(camellia sinensis leaf extract), 조합향료(수용성매스틱검)(Pistacia lentiscus (mastic) gum), 인삼추출물(panax ginseng root extract), 유칼립투스오일(eucalyptus globulus leaf oil), 스피아민트오일(spearmint oil), 향료(flavor) 및 정제수(water)를 포함한다.An antibacterial toothpaste composition with excellent gum disease prevention and bad breath removal effects according to an embodiment of the technical idea of the present invention includes silicon dioxide, sodium monofluorophospate, tocopheryl acetate, and sorbitol solution ( 70% amorphous) (Sorbitol), Hydrated Silica, Carboxymethyl Cellulose Sodium (Cellulose Gum), xylitol, stevioside, ascorbic acid, L-menthol , propolis extract, sage extract (salvia officinalis (sage) extract), rosemary extract (rosmarinus officinalis (rosemary) extract), centella asiatica extract, green tea extract (camellia sinensis leaf extract), combined fragrance (Water-soluble mastic gum) (Pistacia lentiscus (mastic) gum), ginseng extract (panax ginseng root extract), eucalyptus globulus leaf oil, spearmint oil, flavor and purified water. Includes.
또한, 본 발명에 따른 치약조성물은 이산화규소(Silica) 5 내지 7 중량부, 일불소인산나트륨(Sodium Monofluorophospate) 0.5 내지 1 중량부, 토코페롤아세테이트(Tocopheryl Acetate) 0.05 내지 0.25 중량부, 소르비톨액(70% 비결정성)(Sorbitol) 60 내지 70 중량부, 함수규산(Hydrated Silica) 8 내지 12 중량부, 카르복시메틸셀룰로오스나트륨(Cellulose Gum) 0.1 내지 0.3 중량부, 자일리톨(xylitol) 5 내지 10 중량부, 스테비올배당체(stevioside) 0.05 내지 0.15 중량부, 아스코르브산(ascorbic acid) 0.0005 내지 0.0015 중량부, L-멘톨(menthol) 0.2 내지 0.6 중량부, 프로폴리스추출물(propolis extract) 0.0005 내지 0.0015 중량부, 세이지추출물(salvia officinalis (sage) extract) 0.005 내지 0.015 중량부, 로즈마리추출물(rosmarinus officinalis (rosemary) extract) 0.0005 내지 0.0015 중량부, 병풀추출물(Centella asiatica extract) 0.0005 내지 0.0015 중량부, 녹차추출물(camellia sinensis leaf extract) 0.005 내지 0.015 중량부, 조합향료(수용성매스틱검)(Pistacia lentiscus (mastic) gum) 0.0005 내지 0.0015 중량부, 인삼추출물(panax ginseng root extract) 0.005 내지 0.015 중량부, 유칼립투스오일(eucalyptus globulus leaf oil) 0.0005 내지 0.0015 중량부, 스피아민트오일(spearmint oil) 0.1 내지 0.9 중량부, 향료(flavor) 0.1 내지 0.9 중량부 및 정제수(water) 8 내지 12 중량부의 중량 비율로 포함될 수 있다.In addition, the toothpaste composition according to the present invention includes 5 to 7 parts by weight of silicon dioxide, 0.5 to 1 part by weight of sodium monofluorophospate, 0.05 to 0.25 parts by weight of tocopheryl acetate, and sorbitol solution (70 parts by weight) % amorphous) (Sorbitol) 60 to 70 parts by weight, Hydrated Silica (8 to 12 parts by weight), Carboxymethyl Cellulose Sodium (Cellulose Gum) 0.1 to 0.3 parts by weight, xylitol (xylitol) 5 to 10 parts by weight, Stem 0.05 to 0.15 parts by weight of stevioside, 0.0005 to 0.0015 parts by weight of ascorbic acid, 0.2 to 0.6 parts by weight of L-menthol, 0.0005 to 0.0015 parts by weight of propolis extract, sage extract (salvia officinalis (sage) extract) 0.005 to 0.015 parts by weight, rosemary extract (rosmarinus officinalis (rosemary) extract) 0.0005 to 0.0015 parts by weight, Centella asiatica extract (Centella asiatica extract) 0.0005 to 0.0015 parts by weight, green tea extract (camellia sinensis leaf extract) ) 0.005 to 0.015 parts by weight, combined fragrance (water-soluble mastic gum) 0.0005 to 0.0015 parts by weight, 0.005 to 0.015 parts by weight of ginseng extract (panax ginseng root extract), eucalyptus globulus leaf oil ) It may be included in a weight ratio of 0.0005 to 0.0015 parts by weight, 0.1 to 0.9 parts by weight of spearmint oil, 0.1 to 0.9 parts by weight of flavor, and 8 to 12 parts by weight of purified water.
상기 이산화규소(Silica)는 입자가 곱고 부드러우며 둥근 모양의 고급 연마제로, 치아 손상은 줄이고 섬세하게 연마되어 치아를 보호하고 있는 에나멜층의 마모도를 최소화할 수 있다. 또한, 치약조성물의 유효 기간을 보장하고, 수분의 영향으로 부터 보호하며, 성분이 서로 달라붙지 않고 부드럽게 흐를수 있도록 도와줄 수 있다.The silicon dioxide (Silica) is a high-quality abrasive with fine, soft, and round particles. It reduces tooth damage and is delicately polished to minimize wear on the enamel layer that protects the teeth. In addition, it can ensure the shelf life of the toothpaste composition, protect it from the effects of moisture, and help the ingredients flow smoothly without sticking to each other.
상기 이산화규소는 치태제거(안티플라그) 기능을 수행할 수 있는데, 상기 이산화규소의 결정구조 자체가 침강탄산과 달리 둥근 형으로 되어 있어 치아의 연마를 최소화하면서 치아 사이 및 치아 표면에 흡착된 이물질을 제거하여 치태제거(안티플라그)와 동시에 미백 효과를 줄 수 있다.The silicon dioxide can perform a plaque removal (anti-plaque) function. The crystal structure of the silicon dioxide itself is round, unlike precipitated carbonate, so it minimizes polishing of teeth and removes foreign substances adsorbed between teeth and on the tooth surface. It can remove plaque (anti-plaque) and provide a whitening effect at the same time.
상기 일불소인산나트륨(Sodium Monofluorophospate)은 치아의 겉면에 불소를 공급하여 충치를 예방하는 역할을 수행할 수 있다. 또한, 구강내 세균들이 부식성산에 의해 치아 범랑질이 녹는 것을 방지하고 칼슘 공급 촉진 작용으로 치아를 튼튼하게 해주며 치아 겉면에 불소를 공급하여 치아 내산성을 높여주고 충치를 예방하는 역할을 수행할 수 있다.The sodium monofluorophospate can play a role in preventing cavities by supplying fluoride to the surface of teeth. In addition, it prevents oral bacteria from dissolving tooth enamel due to corrosive acid, strengthens teeth by promoting calcium supply, and supplies fluoride to the surface of teeth to increase tooth acid resistance and prevent cavities. .
상기 토코페롤아세테이트(Tocopheryl Acetate)는 비타민E로도 불리며, 잇몸 상피조직의 건강 상태와 관련 있는 영양소이다. 비타민 E는 지용성 비타민으로 총 8종으로 구성되는데, 비타민 E가 체내에서 항산화 작용을 한다는 사실은 유명하다.Tocopheryl Acetate is also called vitamin E and is a nutrient related to the health of gum epithelial tissue. Vitamin E is a fat-soluble vitamin composed of a total of eight types, and it is famous for the fact that vitamin E acts as an antioxidant in the body.
또한, 상기 토코페롤아세테이트(Tocopheryl Acetate)는 세포의 막을 이루는 지질의 과산화를 방지해서 세포막을 튼튼하게 하고, 잇몸을 견고하게 만들 수 있으며, 염증 유발 인자를 억제해 치은염과 치주염을 방지하는 항염 작용을 한다. 또한, 콜레스테롤 입자 속으로 들어가서 혈전(피떡)도 방지하는데, 이를 통해 잇몸까지 혈액 순환이 원활하게 만들어 염증 치유를 도울 수 있다.In addition, the tocopheryl acetate prevents peroxidation of lipids that make up the cell membrane, strengthens the cell membrane and gums, and has an anti-inflammatory effect that prevents gingivitis and periodontitis by suppressing inflammatory factors. . In addition, it enters the cholesterol particles and prevents blood clots, which helps heal inflammation by improving blood circulation to the gums.
상기 소르비톨액(70% 비결정성)(Sorbitol)은 구강의 건조함을 줄여주는 습윤제 역할로, 양치 후 입안이 마르지 않도록 도와줄 수 있다.The sorbitol solution (70% amorphous) (Sorbitol) acts as a humectant to reduce dryness of the mouth and can help prevent the mouth from drying out after brushing teeth.
상기 함수규산(Hydrated Silica)은 부드러운 연마제로 치아의 기계적 청소를 목적으로 사용될 수 있다.The hydrated silica is a soft abrasive and can be used for mechanical cleaning of teeth.
상기 카르복시메틸셀룰로오스나트륨(Cellulose Gum)은 수용액의 고점성을 이용해서 화장수, 유액 및 크림의 점도 조절제, 안정화제로서 이용되고 유액, 크림, 유화 파운데이션류에는 보호콜로이드와 점성을 이용해서 유화, 분산안정성 향상의 목적으로 배합된다. 특히 상기 카르복시메틸셀룰로오스나트륨(Cellulose Gum)을 이용함으로써 계면활성제의 사용량을 줄일 수 있다는 점, 자극성을 완화시키는 작용이 있다는 점 등에서 안전성을 한층 높일 수 있다.The carboxymethyl cellulose sodium (Cellulose Gum) is used as a viscosity regulator and stabilizer for lotions, emulsions, and creams by utilizing the high viscosity of aqueous solutions, and is used as an emulsification and dispersion stability agent in emulsions, creams, and emulsified foundations by using protective colloids and viscosity. It is formulated for the purpose of improvement. In particular, by using the carboxymethyl cellulose sodium (Cellulose Gum), safety can be further improved in that the amount of surfactant used can be reduced and it has the effect of alleviating irritation.
상기 자일리톨(xylitol)은 충치의 원인이 되는 산을 형성하지 않는 천연 소재의 새로운 감미료로, 잇몸질환, 치주질환 및 잇몸 수렴을 기능을 발휘할 수 있다.The xylitol is a new natural sweetener that does not form acids that cause cavities, and can treat gum disease, periodontal disease, and gum convergence.
상기 자일리톨은 WHO, FDA에 검증된 천연 감미료로 뮤탄스균을 막아주는 동시에 구강내 침분비를 촉진시켜 주며, 침에는 치아복원에 필수적인 칼슘성분이 녹아있어 침 분비가 원활할수록 충치가 억제되는데 그래서 자일리톨은 원활한 침분비를 유도함으로써 충치를 억제하는 충치 억제 기능과 아울러 충치 균을 막아주는 기능을 한다.Xylitol is a natural sweetener verified by the WHO and FDA that prevents mutans bacteria and promotes salivary secretion in the oral cavity. Saliva contains dissolved calcium components essential for tooth restoration, so the smoother salivary secretion, the more inhibited cavities are. It has an anti-cavity function that suppresses cavities by inducing smooth saliva secretion and also functions to prevent cavities bacteria.
상기 스테비올배당체(stevioside)는 국화과에 속하는 남아메리카산 식물 스테비아 잎의 달콤한 맛을 내는 화합물이며 스테비아라는 일반명과 여러 상호명으로 마케팅되는 수많은 감미료의 주 성분이다. 스테비아는 설탕의 당분보다 200~300배 높아, 설탕을 대체할 수 있는 천연 감미료로 사용된다.The steviol glycoside (stevioside) is a compound that gives the sweet taste of stevia leaves, a South American plant belonging to the Asteraceae family, and is the main ingredient of many sweeteners marketed under the common name stevia and various trade names. Stevia has 200 to 300 times the sugar content of sugar, so it is used as a natural sweetener that can replace sugar.
상기 아스코르브산(ascorbic acid)은 비타민 C라고도 하는데, 과일 당분, 채소 및 단백질에 함유되어 있는 영양소로 체내에 없어서는 안될 필수 항산화 성분이다.Ascorbic acid, also called vitamin C, is a nutrient contained in fruit sugar, vegetables, and proteins and is an essential antioxidant component in the body.
또한, 물에 잘 녹는 수용성이 특징이며 피부의 결합조직과 지지조직 형성에 도움을 주어 노화를 지연시키는 항산화 효과가 있으며 미백은 물론 콜라겐 형성을 도와 피부를 탄력 있게 가꿔 준다.In addition, it is water-soluble and soluble in water, has an antioxidant effect that delays aging by helping to form connective tissue and support tissue in the skin, and not only whitens, but also helps collagen formation to make the skin more elastic.
상기 L-멘톨(menthol)은 양박하(Mentha piperita와 Mentha arvenisis)에서 얻어지는 페퍼민트 오일 및 박하유의 주요 성분으로, 소염 작용을 통해 가려움증 완화에 도움을 주며 상쾌한 청량감과 온도를 낮춰주는 쿨링 기능을 한다.The L-menthol (menthol) is a major component of peppermint oil and peppermint oil obtained from spearmint (Mentha piperita and Mentha arvenisis). It helps relieve itching through anti-inflammatory action and has a refreshing feeling and cooling function to lower temperature.
상기 프로폴리스추출물(propolis extract)은 항산화 작용과 구강에서의 항균작용을 수행하는 천연 항균물질로 항균 및 항바이러스 항염 작용이 있어 활성산소 관리에 도움을 준다.The propolis extract is a natural antibacterial substance that performs antioxidant and antibacterial activities in the oral cavity, and has antibacterial and antiviral anti-inflammatory effects, helping to manage free radicals.
상기 프로폴리스추출물은 꿀벌이 포플라나무, 유칼리나무, 소나무등의 새싹 및 나무 껍질에서 채취한 성분과 자신의 타액을 섞어 만든 아교 형태의 물질이며, 여러식물의 약효성분인 효모, 왁스, 벌의 타액이 섞인 물질이다. 특히 이 원료에 함유된 프라보노이드라는 성분이 항염 및 항균성을 갖고 있다.The propolis extract is a glue-like substance made by bees by mixing their own saliva with ingredients collected from the buds and bark of poplar trees, eucalyptus trees, pine trees, etc., and the medicinal ingredients of various plants such as yeast, wax, and bee saliva. This is a mixed substance. In particular, the component called flavonoid contained in this raw material has anti-inflammatory and antibacterial properties.
상기 세이지추출물(salvia officinalis (sage) extract)은 세이지로부터 추출될 수 있는데, 상기 세이지는 오래 전부터 만병통치약으로 널리 알려진 약용식물이다. 상기 세이지는 잎을 말려 사용하는데, 강장작용 외에 신경계통이나 소화기계통에 뛰어난 약효가 있으며, 방부, 항균, 항염 등 살균·소독작용이 있어 각종 염증의 소염제로도 쓰인다.The sage extract (salvia officinalis (sage) extract) can be extracted from sage, which is a medicinal plant that has long been widely known as a panacea. The sage is used by drying the leaves. In addition to its tonic effect, it has excellent medicinal effects on the nervous system and digestive system, and has sterilizing and disinfecting effects such as preservative, antibacterial, and anti-inflammatory, so it is also used as an anti-inflammatory agent for various inflammations.
상기 로즈마리추출물(rosmarinus officinalis (rosemary) extract)은 대표적인 약용식물 중 하나로, 통증완화·항균·살균 작용 등이 뛰어나며 보습 효과에도 우수하다. 피부를 부드럽게 진정시켜주어 화장품 원료로 사용되며, 특유의 신선한 향이 뇌의 기능을 활성화 시켜주어 향신료로 많이 사용되며 피부 미용, 입냄새 제거 등에도 도움이 된다.The rosemary extract (rosmarinus officinalis (rosemary) extract) is one of the representative medicinal plants, and has excellent pain relief, antibacterial, and sterilizing effects as well as excellent moisturizing effects. It is used as a cosmetic ingredient as it gently soothes the skin, and its unique fresh scent activates brain function, so it is often used as a spice and is also helpful for skin care and removing bad breath.
상기 병풀추출물(Centella asiatica extract)은 병풀로부터 추출될 수 있는데, 상기 병풀의 잎과 줄기에 있는 마데카식산이란 성분이 염증을 낫게 하고, 종양과 궤양 등의 상처를 치유하는 힘이 있다는 게 밝혀지면서 연고나 치약, 화장품 등의 원료로도 많이 쓰이고 있다.The Centella asiatica extract can be extracted from Centella asiatica, and it has been discovered that the ingredient called madecassic acid in the leaves and stems of Centella asiatica has the power to relieve inflammation and heal wounds such as tumors and ulcers. It is also widely used as a raw material for ointments, toothpaste, and cosmetics.
상기 병풀추출물(Centella asiatica extract)은 상처 치유와 항산화 효능에 사용되는 병풀잎의 추출물로 피부 재생과 항균, 항염, 항산화, 피부톤 개선 작용을 하고 피부 노화 방지와 트러블 완화에 도움을 주며 소독 작용을 하여 흉터를 개선해주고 탄력을 증진시킨다.Centella asiatica extract is an extract of Centella asiatica leaves that is used for wound healing and antioxidant effects. It has skin regeneration, antibacterial, anti-inflammatory, antioxidant, and skin tone improvement effects, helps prevent skin aging, relieves troubles, and has a disinfecting effect. Improves scars and improves elasticity.
상기 녹차추출물(camellia sinensis leaf extract)은 항산화물질과 영양분이 풍부하게 함유되어 면역력을 강화하고 여러 질병을 예방해주며 산화방지제가 풍부하게 함유되어 있어 만성 질환을 예방해주고 피부 노화를 막아준다.The green tea extract (camellia sinensis leaf extract) is rich in antioxidants and nutrients, strengthens immunity and prevents various diseases, and is rich in antioxidants, preventing chronic diseases and preventing skin aging.
한의학에서는 치아를 보호하기 위해서 녹차를 사용해오고 있는데, 치아 뿐만 아니라 입안에 감염된 것이 있을 때나 입냄새를 없애기 위해서도 녹차가 이용될 수 있다.In Oriental medicine, green tea has been used to protect teeth, and green tea can be used not only for teeth but also when there is an infection in the mouth or to eliminate bad breath.
상기 녹차추출물은 항산화제가 풍부하여 세균으로부터 치아를 보호하고 염증을 줄여주며, 카테킨 성분으로 세포의 손상을 예방하고 노화를 유발하는 활성 산소의 형성을 억제하여 세포의 손상을 보호한다.The green tea extract is rich in antioxidants, which protects teeth from bacteria and reduces inflammation. The catechin component prevents cell damage and inhibits the formation of free radicals that cause aging, protecting cells from damage.
상기 조합향료(수용성매스틱검)(Pistacia lentiscus (mastic) gum)인 매스틱검은 그리스 에게해의 "키오스 섬에서만" 자라는 매스틱 나무의 끈적한 액체 형태의 수액을 채취한 다음에 건조해 굳힌 것으로, 수액이 흘러나오는 모양이 눈물과 비슷해 "신의 눈물", "신이 내린 눈물" 등으로 불린다.Mastic gum, which is the combined flavoring agent (water-soluble mastic gum) (Pistacia lentiscus (mastic) gum), is made by collecting the sticky liquid sap of the mastic tree that grows only on the island of Chios in the Aegean Sea in Greece, then drying and hardening it. , The shape of the sap flowing out resembles tears, so it is called “God’s tears” or “God’s tears.”
상기 조합향료(수용성매스틱검)(Pistacia lentiscus (mastic) gum)는 미국, 일본 등 세계 각국 식약처 개별 인정형 원료로 인정되어 체내 염증을 유발하는 효소의 합성을 저해하고 활성산소를 제거하는 항산화 효과를 지닌 것으로 유명하다.The above combined flavoring agent (water-soluble mastic gum) (Pistacia lentiscus (mastic) gum) is recognized as an individually approved raw material by the Food and Drug Administration in countries around the world, including the United States and Japan, and is an antioxidant that inhibits the synthesis of enzymes that cause inflammation in the body and removes free radicals. It is famous for its effectiveness.
또한, 자일리톨, 프로폴리스와 어깨를 나란히 하는 세계 3대 천연 항염물질로 알려져 있으며 그리스인들이 소화불량, 위 통증, 위궤양 증상 등을 완화시킬 목적으로 매스틱을 껌처럼 씹어서 수액추출물만 섭취 후 내용물을 뱉어내는데 실제로 구강 내의 세균을 억제하는 항염효과가 뛰어나 치약이나 구강 청결제 등에서 주성분으로 사용이 되고 있다.In addition, it is known as one of the world's top three natural anti-inflammatory substances, on par with xylitol and propolis. The Greeks chew mastic like gum to relieve symptoms of indigestion, stomach pain, and gastric ulcers, ingesting only the sap extract, and then consuming the contents. It is spit out and has an excellent anti-inflammatory effect that suppresses bacteria in the mouth, so it is used as the main ingredient in toothpaste and mouthwash.
상기 인삼추출물(panax ginseng root extract)은 인삼으로부터 추출될 수 있는데, 상기 인삼은 원기를 보하고 신체허약, 권태, 피로, 식욕부진, 구토, 설사에 쓰이며 폐기능을 도우며 진액을 생성하고 안신작용 및 신기능을 높여 준다. 약리작용은 대뇌피질흥분과 억제, 평형, 항피로, 항노화, 면역증강, 심장수축, 성선촉진, 고혈당억제, 단백질합성촉진, 항상성유지, 항암, 해독작용 등이 보고되었다.The ginseng extract (panax ginseng root extract) can be extracted from ginseng, which restores vitality and is used for physical weakness, boredom, fatigue, loss of appetite, vomiting, and diarrhea, helps lung function, produces essence, and has ocular and renal effects. Increases renal function. Pharmacological effects have been reported to include cerebral cortex excitement and inhibition, balance, anti-fatigue, anti-aging, immune enhancement, cardiac contraction, gonadotropism, hyperglycemia suppression, protein synthesis promotion, homeostasis maintenance, anti-cancer, and detoxification.
상기 유칼립투스오일(eucalyptus globulus leaf oil)은 유칼립투스로부터 추출될 수 있는데, 상기 유칼립투스는 세계적으로 가장 유용한 나무 중의 하나로 호주 원주민들은 가벼운 상처와 진균 감염에 유칼립투스 잎을 으깨어 사용했고, 기관지염, 기침 등 호흡기 질환에 잎과 오일을 사용하였다. 1852년 유칼립투스가 유럽에 전파된 후 서양의학과 허브의학에서 말라리아, 콜레라, 장티푸스 등의 감염증과 열병, 천식에 사용되었고, 강한 살균, 항박테리아 효과가 과학적으로 입증되어 인후염, 기관지염, 감기 등 호흡계 증상 치료와 전염병 예방, 소독제로 널리 사용되고 있다. 오늘날 구강 세척제, 가글, 치약, 진통연고의 주 원료로도 사용된다.The eucalyptus globulus leaf oil can be extracted from eucalyptus, which is one of the most useful trees in the world. Australian indigenous people used crushed eucalyptus leaves for minor wounds and fungal infections, and used it for respiratory diseases such as bronchitis and cough. Leaves and oil were used. After eucalyptus was introduced to Europe in 1852, it was used in Western medicine and herbal medicine to treat infections such as malaria, cholera, and typhoid fever, and asthma. Its strong sterilizing and antibacterial effects were scientifically proven to treat respiratory symptoms such as sore throat, bronchitis, and colds. It is widely used to prevent infectious diseases and as a disinfectant. Today, it is also used as the main ingredient in mouthwash, gargle, toothpaste, and pain reliever ointment.
상기 유칼립투스는 상처의 치료 및 감염, 염증과 통증을 완화시키는데 사용되며 항염, 항균, 항산화 작용을 하고 피부의 미용 및 노화 방지에 도움이 된다. 세균 증식을 억제하여 충치를 예방하는 효과가 있으며 각종 염증성 구강질환의 개선에 도움을 주고, 살균소독의 효과로 입냄새를 완화시키는데 도움을 준다.The eucalyptus is used to treat wounds and relieve infection, inflammation and pain, and has anti-inflammatory, antibacterial and antioxidant effects, and is helpful for skin beauty and anti-aging. It is effective in preventing cavities by suppressing bacterial growth, helps improve various inflammatory oral diseases, and helps relieve bad breath through its sterilizing and disinfecting effect.
상기 스피아민트오일(spearmint oil)은 스피아민트로부터 제조될 수 있는데, 유럽지역이 원산지인 스피아민트는 수많은 민트 중 애플민트, 페퍼민트와 함께 3대 민트로 꼽힌다.The spearmint oil can be manufactured from spearmint. Spearmint, which is native to Europe, is considered one of the three major mints along with apple mint and peppermint among the numerous mints.
상기 스피아민트는 기분을 상쾌하게 하고 달콤하고 강한 박하향이 있어 치약, 껌, 사탕, 구강세정제 등의 향료로 주로 쓰이며 진정, 진통 효과를 얻기위해 사용되고, 코막힘, 두통 등 진정시키며 시원한 향으로 입냄새제거 스트레스 해소에도 도움이 되며, 구강 위생이나 잇몸 궤양치료, 치아 미백에도 사용되며 구강세정제의 향료로 입냄새 제거에 도움을 준다.The spearmint refreshes the mood and has a sweet and strong mint flavor, so it is mainly used as a flavoring for toothpaste, gum, candy, and mouthwash, and is used to obtain a soothing and analgesic effect. It soothes stuffy noses, headaches, etc., and has a cool scent to relieve bad breath. It helps relieve stress, and is also used for oral hygiene, gum ulcer treatment, and teeth whitening. It is also used as a flavoring agent in mouthwash to help eliminate bad breath.
상기 향료(flavor)는 착향제로, 구취 제거 기능을 하기 위하여 사용될 수 있다.The flavor is a flavoring agent and can be used to remove bad breath.
상기 향료는 당해 기술분야에서 공지된 다양한 종류의 향료가 사용될 수 있는데, 설명의 편의 및 본 발명의 기술적 사상의 명확성을 위하여 이에 대한 구체적인 설명은 생략하기로 한다.The above-described fragrance may include various types of fragrance known in the art. For convenience of explanation and clarity of the technical idea of the present invention, detailed description thereof will be omitted.
상기 정제수(water)는 용제로서, 조성물을 배합하기 위하여 사용될 수 있다.The purified water can be used as a solvent to mix the composition.
예를 들어, 상기 정제수로는 이온수를 사용하거나 자화 처리된 자화수를 사용할 수 있는데, 예를 들어, 상기 자화수(磁化水)는 물에 자력(磁力)을 가하여 잘게 쪼개져 인체 흡수성이 향상되고, 침투력이 강하게 됨에 따라 조성물의 침투성을 향상시킬 수 있다.For example, the purified water may be ionized water or magnetized water that has been magnetized. For example, the magnetized water is split into small pieces by applying a magnetic force to the water, improving its absorption into the human body and its penetration power. As it becomes stronger, the permeability of the composition can be improved.
이하, 첨부된 도면을 참조하여 본 발명의 기술적 사상의 일 실시예에 따른 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물에 대한 실시예 및 비교예를 들어 더욱 구체적으로 설명하기로 한다.Hereinafter, with reference to the attached drawings, an antibacterial toothpaste composition with excellent gum disease prevention and bad breath removal effects according to an embodiment of the technical idea of the present invention will be described in more detail through examples and comparative examples.
< 실시예 ><Example>
이산화규소 6 중량부, 일불소인산나트륨 0.74 중량부, 토코페롤아세테이트 0.18 중량부, 소르비톨액 64 중량부, 함수규산 10 중량부, 카르복시메틸셀룰로오스나트륨 0.2 중량부, 자일리톨 7 중량부, 스테비올배당체 0.1 중량부, 아스코르브산 0.001 중량부, L-멘톨 0.4 중량부, 프로폴리스추출물 0.001 중량부, 세이지추출물 0.01 중량부, 로즈마리추출물 0.001 중량부, 병풀추출물 0.001 중량부, 녹차추출물 0.01 중량부, 조합향료(수용성매스틱검) 0.001 중량부, 인삼추출물 0.01 중량부, 유칼립투스오일 0.001 중량부, 스피아민트오일 0.5 중량부, 향료 0.5 중량부 및 정제수 10.344 중량부로 이루어진 조성물을 혼합하여 치약을 제조하였다.6 parts by weight of silicon dioxide, 0.74 parts by weight of sodium monofluorophosphate, 0.18 parts by weight of tocopherol acetate, 64 parts by weight of sorbitol solution, 10 parts by weight of hydrous silicic acid, 0.2 parts by weight of sodium carboxymethyl cellulose, 7 parts by weight of xylitol, 0.1 parts by weight of steviol glycoside parts, ascorbic acid 0.001 parts by weight, L-menthol 0.4 parts by weight, propolis extract 0.001 parts by weight, sage extract 0.01 parts by weight, rosemary extract 0.001 parts by weight, centella asiatica extract 0.001 parts by weight, green tea extract 0.01 parts by weight, combined flavor (water soluble) Toothpaste was prepared by mixing a composition consisting of 0.001 parts by weight of mastic gum, 0.01 parts by weight of ginseng extract, 0.001 parts by weight of eucalyptus oil, 0.5 parts by weight of spearmint oil, 0.5 parts by weight of fragrance, and 10.344 parts by weight of purified water.
< 비교예 ><Comparative example>
시중에 판매되고 있는 치약(L사 제조)을 구입한 후 이를 비교예에 따른 치약으로 사용하였다.A commercially available toothpaste (manufactured by L Company) was purchased and used as the toothpaste according to the comparative example.
1. 살균 시험1. Sterilization test
실시예에 따른 치약의 살균 시험을 수행하였다.A sterilization test of the toothpaste according to the example was performed.
도 1은 실시예에 따른 치약의 살균 시험 결과를 보여주는 시험성적서이다.Figure 1 is a test report showing the results of a sterilization test of toothpaste according to an example.
도 1을 참조하면, 시험균주 S. mutans ATCC 25175를 이용하여 수행된 실시예에 따른 치약은 입속 세균, 충치의 원인인 뮤탄스균을 97% 이상 감소시켜 우수한 살균력, 항균력을 가짐을 확인할 수 있다.Referring to Figure 1, it can be seen that the toothpaste according to the example performed using the test strain S. mutans ATCC 25175 has excellent sterilizing and antibacterial properties by reducing oral bacteria and mutans bacteria, which cause cavities, by more than 97%.
2. 유해성분 포함 여부 확인 시험2. Test to check whether harmful ingredients are included
실시예에 따른 치약의 합성계면활성제 등 유해성분 포함 여부를 확인하였다.It was confirmed whether the toothpaste according to the example contained harmful ingredients such as synthetic surfactants.
도 2는 실시예에 따른 치약의 유해성분 포함 여부에 대한 확인서이다.Figure 2 is a confirmation of whether toothpaste according to an example contains harmful ingredients.
도 2를 참조하면, 실시예에 따른 치약은 합성계면활성제, 파라벤, MIT, CMIT, 인공색소, 인공유화제, PEG, 안식향산류, 벤조산나트륨, 광물성오일, 미세플라스틱, 사카린, 합성보존제 등의 유해성분이 포함되지 않은 안전하고 친환경적인 치약임을 확인할 수 있다.Referring to Figure 2, the toothpaste according to the example contains harmful ingredients such as synthetic surfactants, parabens, MIT, CMIT, artificial colors, artificial emulsifiers, PEG, benzoic acids, sodium benzoate, mineral oil, microplastics, saccharin, and synthetic preservatives. You can confirm that it is a safe and eco-friendly toothpaste that does not contain any ingredients.
3. PCR 및 RDA의 측정3. PCR and measurement of RDA
실시예 및 비교예에 따라 제조된 치약의 세정능력 및 연마력을 알아보기 위하여, 실시예 및 비교예에서 제조된 치약을 대상으로 통상적인 지방막세정비율(PCR, Pellicle Cleaning Ratio) 및 방사능상아질 연마(RDA, Radioactive Dentine Abrasivity) 값을 측정하였고, 그 결과를 하기의 [표 1]에 나타내었다.In order to determine the cleaning ability and polishing power of the toothpaste prepared in Examples and Comparative Examples, the toothpaste prepared in Examples and Comparative Examples was tested for the typical fat film cleaning ratio (PCR, Pellicle Cleaning Ratio) and radioactive dentin polishing ( RDA (Radioactive Dentine Abrasivity) values were measured, and the results are shown in [Table 1] below.
상기 [표 1]을 참조하면, 실시예에 따른 치약은 비교예에 따른 치약에 비해 PCR 및 RDA 값이 높은 것으로 나타났다. 따라서, 실시예에 따른 치약은 플라그 제거 효과가 우수한 것으로 확인되었다.Referring to [Table 1], the toothpaste according to the example showed higher PCR and RDA values than the toothpaste according to the comparative example. Therefore, it was confirmed that the toothpaste according to the example had an excellent plaque removal effect.
4. MIC 측정4. MIC measurement
실시예 및 비교예에 따라 제조된 치약에 대한 충치균과 치주질환 원인균에 대한 항균작용을 알아보기 위해 MIC 측정을 수행하였다.MIC measurements were performed to determine the antibacterial effect of toothpastes prepared according to Examples and Comparative Examples against caries bacteria and periodontal disease-causing bacteria.
CPC를 농도별로 함유한 Brain heart Infusion agar(BHIA)를 사용하여 한천배지 희석법으로 항균력을 평가하였다.Brain heart infusion agar (BHIA) containing CPC at different concentrations was used to evaluate antibacterial activity using the agar dilution method.
치주질환원인균의 경우, 35℃, 6% CO2 조건하에서 6일간 배양하였고, 충치원인균의 경우, 35℃, 호기성 조건하에서 3일간 배양한 후 세균의 발육을 억제하는 최소농도를 최소발육억제농도(MIC)로 결정하였다.In the case of periodontal disease-causing bacteria, the bacteria were cultured for 6 days at 35°C and 6% CO2 , and in the case of cavity-causing bacteria, the minimum concentration that inhibits bacterial growth was determined after culturing for 3 days at 35°C and aerobic conditions (minimum growth inhibitory concentration). MIC) was determined.
또한, 실시예 및 비교예를 농도별로 함유한 BHIA를 사용하여 한천배지 희석법으로 항균력을 평가하였다. 시험농도는 시험치약의 50배 희석농도부터 2배씩 희석하여 총 10단계의 희석농도에서 수행하였고, 그 결과를 하기의 [표 2]에 나타내었다.In addition, the antibacterial activity was evaluated using BHIA containing the Examples and Comparative Examples at different concentrations by the agar medium dilution method. The test concentration was performed at a total of 10 levels of dilution, starting from 50 times the dilution of the test toothpaste and diluting it 2 times at a time, and the results are shown in [Table 2] below.
(1) 시험균(1) Test bacteria
치주질환원인균: 액션바실러스 액티노마이세템코미탄스(Actionbacilus Actinomycetemcomitans ATCC 29522), 후소박테리움 뉴클레아툼(Fusobacterium nucleatum ATCC 25586)Periodontal disease-causing bacteria: Actionbacilus Actinomycetemcomitans ATCC 29522, Fusobacterium nucleatum ATCC 25586
충치원인균: 액티노마이시스 비스코서스(Actinomyces viscosus ATCC 158987)Cavity-causing bacteria: Actinomyces viscosus ATCC 158987
(2) 사용배지(2) Medium used
혈액 한천 배지(혈액한천 베이스 + 최종농도 5 %의 양 혈액) BHI 한천Blood agar medium (blood agar base + sheep blood at final concentration 5%) BHI agar
상기 [표 2]를 참조하면, 각 시험균에 항균력을 나타내기 위한 MIC는 3.3 내지 8.8μg/mL로 나타났으며, 실시예의 치약이 비교예의 치약에 비해 항균성이 우수함을 알 수 있었다.Referring to [Table 2], the MIC for antibacterial activity against each test bacteria was found to be 3.3 to 8.8 μg/mL, and it was found that the toothpaste of the example had superior antibacterial activity compared to the toothpaste of the comparative example.
5. 치약 조성물의 구취제거 효과5. Bad breath removal effect of toothpaste composition
치약에 대한 구취제거 효과를 알아보기 위하여, 평상시에 구취가 있다고 자각하고 있는 35명(남성 17명: 여성 18명)을 대상으로 동일한 식사를 하게 한 후, 통상적인 할리메타를 이용하여 구취의 정도를 정량화하였다.In order to determine the effectiveness of toothpaste in removing bad breath, 35 people (17 men: 18 women) who were aware of having bad breath on a regular basis were asked to eat the same meal, and then the degree of bad breath was measured using a standard Halimeta. was quantified.
양치 전과 후의 할리메타 수치의 차이를 구하고 평균값을 측정하였으며, 그 결과를 하기의 [표 3]에 나타내었다.The difference in Halimeta levels before and after brushing was determined and the average value was measured, and the results are shown in [Table 3] below.
상기 [표 3]을 참조하면, 실시예에 따라 제조된 치약이 비교예에 따라 제조된 치약에 비해 구취 효과가 우수한 것을 확인할 수 있었다.Referring to [Table 3], it was confirmed that the toothpaste prepared according to the example had an excellent bad breath effect compared to the toothpaste prepared according to the comparative example.
6. 미백효과 측정 실험6. Whitening effect measurement experiment
측정방법은 피실험자들을 대상으로 4개월 동안 실시예 및 비교예를 치약으로 사용하게 하면서 미백효과를 측정하였다. 피실험자 50명을 선발하여 사전에 색조계(Trubyte Bioform)로 색조를 측정한 후, 색조의 평균값이 거의 동일한 10명씩 5군(실시예 사용자 10명, 비교예 사용자 각각 10명)으로 분류하여 각각에게 실시예 및 비교예의 치약을 분배하여 사용하도록 하였다.The measurement method was to measure the whitening effect by having subjects use the examples and comparative examples as toothpaste for 4 months. After selecting 50 test subjects and measuring their color tone with a color scale (Trubyte Bioform) in advance, they were divided into 5 groups of 10 people each with almost the same average color value (10 example users and 10 comparative example users), and each was given a test. The toothpastes of Examples and Comparative Examples were distributed and used.
치아의 명도(明度) 증가를 확인하기 위하여 투루바이트바이오폼(Trubyte Bioform) 색조계에 있어서 24종의 명도별 표준기준 가운데 관능적으로 식별이 용이한 10종을 선별하고 각각에 대하여 명도 값을 최저 1점에서 최고 10점까지 평가 점수를 부여하였다. 각각의 치약을 사용하기 전에 각 군별로 치아의 명도 값을 상기의 기준에 의거하여 소수점 이하 첫째 자릿수까지 평가하고, 4개월 동안 양치질 한 후의 명도 값을 평가하였다.In order to confirm the increase in the brightness of teeth, 10 types that are easy to distinguish sensory-wise are selected among the 24 standard standards for brightness in the Trubyte Bioform color scale, and the brightness value for each is set to a minimum of 1. Evaluation scores were given up to a maximum of 10 points. Before using each toothpaste, the brightness value of the teeth in each group was evaluated to the first decimal place based on the above standards, and the brightness value after brushing for 4 months was evaluated.
상기 [표 4]를 참조하면, 실시예에 따른 치약이 비교예에 따른 치약에 비해 명도값이 증가하였는데, 이를 통해 실시예에 따른 치약은 치아 미백 및 치석 제거 효과가 우수함을 확인할 수 있었다.Referring to [Table 4], the brightness value of the toothpaste according to the example increased compared to the toothpaste according to the comparative example, through which it was confirmed that the toothpaste according to the example had excellent teeth whitening and tartar removal effects.
7. 사용감 관능 평가7. Sensory evaluation of feeling of use
실시예 및 비교예에 따른 치약을 4주 동안 사용한 후에 거품력, 사용 후 입마름, 자극감, 개운함 등의 사용감에 대한 만족도를 5점 척도 기준으로 평가하도록 한 후, 그 평균 값으로 관능 평가를 수행하였고, 그 결과를 하기의 [표 5]에 나타내었다.After using the toothpaste according to the examples and comparative examples for 4 weeks, satisfaction with the feeling of use, such as foaming power, dry mouth after use, irritation, and refreshment, was evaluated on a 5-point scale, and then a sensory evaluation was performed using the average value. , the results are shown in [Table 5] below.
사용감에 대한 만족도의 기준은 5점 척도 기준으로 평가하였다.The standard of satisfaction with the feeling of use was evaluated on a 5-point scale.
(1점: 매우 불만족, 2점: 불만족, 3점: 보통, 4점: 만족, 5점: 매우 만족)(1 point: very dissatisfied, 2 points: dissatisfied, 3 points: average, 4 points: satisfied, 5 points: very satisfied)
상기 [표 5]를 참조하면, 실시예에 따른 치약은 합성계면활성제가 포함되지 않아 거품의 생성은 적으나, 사용 후 입마름이 적고, 자극적이지 않으며, 상쾌하고 개운함을 느낄 수 있음을 확인할 수 있다.Referring to [Table 5], it can be seen that the toothpaste according to the example does not contain synthetic surfactants, so it generates less foam, but after use, dry mouth is less, it is not irritating, and you can feel refreshed and refreshed. there is.
이상, 본 발명의 바람직한 일 실시예를 설명하였지만, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 본 발명이 그 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 일 실시예는 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.Although a preferred embodiment of the present invention has been described above, those skilled in the art will understand that the present invention can be implemented in other specific forms without changing the technical idea or essential features. You will be able to. Therefore, the embodiment described above should be understood as illustrative in all respects and not restrictive.
Claims (2)
Silicon dioxide, Sodium Monofluorophospate, Tocopheryl Acetate, Sorbitol, Hydrated Silica, Sodium Carboxymethyl Cellulose (Cellulose Gum), Xylitol, Stem stevioside, ascorbic acid, L-menthol, propolis extract, salvia officinalis (sage) extract, rosmarinus officinalis (rosemary) extract, Centella asiatica extract, green tea extract (camellia sinensis leaf extract), combined fragrance (Pistacia lentiscus (mastic) gum), ginseng extract (panax ginseng root extract), eucalyptus globulus leaf oil ), an antibacterial toothpaste composition with excellent gum disease prevention and bad breath removal effects, comprising spearmint oil, flavor, and purified water.
상기 이산화규소(Silica) 5 내지 7 중량부, 일불소인산나트륨(Sodium Monofluorophospate) 0.5 내지 1 중량부, 토코페롤아세테이트(Tocopheryl Acetate) 0.05 내지 0.25 중량부, 소르비톨액(Sorbitol) 60 내지 70 중량부, 함수규산(Hydrated Silica) 8 내지 12 중량부, 카르복시메틸셀룰로오스나트륨(Cellulose Gum) 0.1 내지 0.3 중량부, 자일리톨(xylitol) 5 내지 10 중량부, 스테비올배당체(stevioside) 0.05 내지 0.15 중량부, 아스코르브산(ascorbic acid) 0.0005 내지 0.0015 중량부, L-멘톨(menthol) 0.2 내지 0.6 중량부, 프로폴리스추출물(propolis extract) 0.0005 내지 0.0015 중량부, 세이지추출물(salvia officinalis (sage) extract) 0.005 내지 0.015 중량부, 로즈마리추출물(rosmarinus officinalis (rosemary) extract) 0.0005 내지 0.0015 중량부, 병풀추출물(Centella asiatica extract) 0.0005 내지 0.0015 중량부, 녹차추출물(camellia sinensis leaf extract) 0.005 내지 0.015 중량부, 조합향료(수용성매스틱검)(Pistacia lentiscus (mastic) gum) 0.0005 내지 0.0015 중량부, 인삼추출물(panax ginseng root extract) 0.005 내지 0.015 중량부, 유칼립투스오일(eucalyptus globulus leaf oil) 0.0005 내지 0.0015 중량부, 스피아민트오일(spearmint oil) 0.1 내지 0.9 중량부, 향료(flavor) 0.1 내지 0.9 중량부 및 정제수(water) 8 내지 12 중량부의 중량 비율로 포함된 것을 특징으로 하는 잇몸질환 예방과 구취제거 효과가 우수한 항균치약 조성물.According to clause 1,
5 to 7 parts by weight of silicon dioxide, 0.5 to 1 part by weight of sodium monofluorophospate, 0.05 to 0.25 parts by weight of tocopheryl acetate, 60 to 70 parts by weight of sorbitol, water 8 to 12 parts by weight of Hydrated Silica, 0.1 to 0.3 parts by weight of sodium carboxymethyl cellulose (Cellulose Gum), 5 to 10 parts by weight of xylitol, 0.05 to 0.15 parts by weight of stevioside, ascorbic acid ( ascorbic acid) 0.0005 to 0.0015 parts by weight, L-menthol (menthol) 0.2 to 0.6 parts by weight, propolis extract (propolis extract) 0.0005 to 0.0015 parts by weight, sage extract (salvia officinalis (sage) extract) 0.005 to 0.015 parts by weight, Rosemary extract (rosmarinus officinalis (rosemary) extract) 0.0005 to 0.0015 parts by weight, Centella asiatica extract (Centella asiatica extract) 0.0005 to 0.0015 parts by weight, green tea extract (camellia sinensis leaf extract) 0.005 to 0.015 parts by weight, combined flavor (water-soluble mastic gum) ) (Pistacia lentiscus (mastic) gum) 0.0005 to 0.0015 parts by weight, ginseng extract (panax ginseng root extract) 0.005 to 0.015 parts by weight, eucalyptus oil (eucalyptus globulus leaf oil) 0.0005 to 0.0015 parts by weight, spearmint oil An antibacterial toothpaste composition with excellent gum disease prevention and bad breath removal effects, comprising 0.1 to 0.9 parts by weight of flavor, 0.1 to 0.9 parts by weight of flavor, and 8 to 12 parts by weight of purified water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220053798A KR20230153847A (en) | 2022-04-29 | 2022-04-29 | Antibacterial toothpaste composition with excellent effect of preventing gum disease and removing bad breath |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220053798A KR20230153847A (en) | 2022-04-29 | 2022-04-29 | Antibacterial toothpaste composition with excellent effect of preventing gum disease and removing bad breath |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230153847A true KR20230153847A (en) | 2023-11-07 |
Family
ID=88747127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220053798A KR20230153847A (en) | 2022-04-29 | 2022-04-29 | Antibacterial toothpaste composition with excellent effect of preventing gum disease and removing bad breath |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230153847A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101250567B1 (en) | 2010-06-11 | 2013-04-03 | (주)네오메디컬 | Functional ToothPaste Composition |
KR101992927B1 (en) | 2017-11-15 | 2019-06-25 | 주식회사 비온뒤컴퍼니 | Toothpaste composition for prevention and improvement of periodontal disease |
KR102299387B1 (en) | 2019-07-16 | 2021-09-07 | (주)한일제약 | Antimicrobial toothpaste composition |
-
2022
- 2022-04-29 KR KR1020220053798A patent/KR20230153847A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101250567B1 (en) | 2010-06-11 | 2013-04-03 | (주)네오메디컬 | Functional ToothPaste Composition |
KR101992927B1 (en) | 2017-11-15 | 2019-06-25 | 주식회사 비온뒤컴퍼니 | Toothpaste composition for prevention and improvement of periodontal disease |
KR102299387B1 (en) | 2019-07-16 | 2021-09-07 | (주)한일제약 | Antimicrobial toothpaste composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101723588B1 (en) | Composition for mouth comprising camellia japonica l leaf extract and manufacturing method thereof | |
KR101955468B1 (en) | Preparing method for toothpaste composition comprising natural extracts | |
KR102610236B1 (en) | Toothpaste composition for improving or preventing bad breath | |
KR20170019893A (en) | Toothpaste compositions comprising niosome containing natural plant extract | |
KR101985771B1 (en) | Foaming solid formulation for mouthwash and preperation method thereof | |
KR101251161B1 (en) | Composition of Toothpaste and Method of Preparing thereof | |
KR101216427B1 (en) | Calendula officinalis dentifrice composition and process for preparing the same | |
KR19980013946A (en) | Oral composition of liquid type | |
KR20190094987A (en) | Composition for prevention or treatment of oral disease comprising Ginkgo biloba extract | |
KR102221423B1 (en) | Composition for inhibiting halitosis and enhancing oral hygiene | |
KR101660467B1 (en) | Oral composition containing fermentative extract of lycii fructus as active ingredient | |
KR101916377B1 (en) | Composition for teeth whitening and preparation method therefor | |
KR101703269B1 (en) | Oral care composition comprising Magnolia officinalis extract and bicarbonate | |
KR102171798B1 (en) | Composition for treating oral disease and inhibiting halitosis containing natural extracts and preparation method therefor | |
KR980008209A (en) | Toothpaste composition | |
KR102373373B1 (en) | Oral composition for preventing halitosis | |
KR102597684B1 (en) | Oral composition comprising amaranth extract | |
RU2306922C2 (en) | Using of grass decoctions as water medium in producing of tooth-paste and tooth-paste composition | |
KR20230153847A (en) | Antibacterial toothpaste composition with excellent effect of preventing gum disease and removing bad breath | |
KR20170142740A (en) | Composition for treating or preventing oral diseases comprising natural complex | |
KR20180047704A (en) | Composition for prevention or treatment of oral disease comprising Scutellaria baicalensis extract | |
KR102177066B1 (en) | Composition for prevention or treatment of oral disease comprising Epimedium Herb extract | |
RU2355379C1 (en) | Therapeutic-preventive dentifrice water and method for making thereof | |
KR102704053B1 (en) | Manufacturing method of toothpaste composition including ingredient of improving oral dryness | |
KR102622954B1 (en) | Toothpaste composition for improving or preventing gingivitis and periodontitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |